Trial Site Detail
Drug: |
IDRX-42 |
|||
|---|---|---|---|---|
Trial: |
A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST1] |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
University of Miami, Sylvester Comprehensive Cancer Center1475 Northwest 12th Ave |
Principal Investigator: |
Jon Trent, MD PhD |
|---|---|
Contact: |
nxr518@med.miami.edu 305-243-8175 |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
University of Miami, Sylvester Comprehensive Cancer Center Website: |
http://uhealthsystem.com/clinical-trials/browse-clinical-trials/results?tarea=Bone%20and%20Soft%20Tissue%20Cancers&division=Cancer%20Center |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.